| View |
|
DRP-4444-02
|
Guaifenesin + Phenylpropanolamine Hydrochloride + Chlorphenamine maleate
|
Conzend
|
50mg/6.25mg/1mg per 5mL
|
Syrup
|
Expectorant/ Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 March 2024
|
06 June 2025
|
| View |
|
DRP-4515-10
|
Cefuroxime (as sodium)
|
Cefupen 750
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Zazen Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 March 2024
|
18 July 2028
|
| View |
|
DRP-4720-02
|
Salmeterol (as xinafoate) + Fluticasone Propionate
|
Zerehaler
|
25 mcg/250 mcg
|
Metered Dose Inhaler (CFC Free)
|
Fixed Dose Combination Inhalation Corticosteroid and Beta-2 Adrenoceptor Agonist
|
Kopran Limited
|
India
|
CLIDP Conversion
|
08 March 2024
|
18 March 2028
|
| View |
|
DRP-4815-07
|
Lactulose
|
Rexulac
|
3.35 g/ 5mL
|
Syrup
|
Osmotic Laxative
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
28 March 2024
|
10 February 2027
|
| View |
|
DRP-4838-07
|
Fenofibrate
|
Fenogen
|
200 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
21 March 2024
|
16 October 2028
|
| View |
|
DRP-4838-08
|
Fenofibrate
|
Fenoceed
|
200 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
28 March 2024
|
16 October 2028
|
| View |
|
DRP-4839-07
|
Fenofibrate
|
Tripibra
|
160 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
10 March 2024
|
16 October 2028
|
| View |
|
DRP-4839-09
|
Fenofibrate
|
Fenoceed
|
160 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 March 2024
|
16 October 2028
|
| View |
|
DRP-4948-15
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Piperwell
|
4 g /500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin with Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 March 2024
|
22 November 2028
|
| View |
|
DRP-15061
|
Rabeprazole sodium
|
Rabazio 20
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Agio Pharmaceuticals Ltd.
|
India
|
Initial
|
01 April 2024
|
01 April 2029
|
| View |
|
DR-XY49031
|
Ceftriaxone (as sodium)
|
Ceftrash-1000
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Third-Generation Cephalosporin)
|
Shamshree Lifesciences Ltd.
|
India
|
Initial
|
01 April 2024
|
01 April 2029
|
| View |
|
DRP-15060
|
Nicardipine hydrochloride
|
Nicardilex
|
1 mg/mL (20 mg/20 mL)
|
Solution for Injection (I.V.)
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
United Biotech Pvt. Ltd.
|
India
|
Initial
|
01 April 2024
|
01 April 2029
|
| View |
|
DR-XY49001
|
Levonorgestrel
|
Levoplant
|
75 mg
|
Subdermal Implant
|
Hormonal Contraceptive (Progestogen)
|
Shanghai Dahua Pharmaceutical Co., Ltd. 3503
|
China
|
Monitored Release (Re-application)
|
15 March 2024
|
15 March 2029
|
| View |
|
DRP-15066
|
Hydrocortisone (as sodium succinate)
|
Droxisur 100
|
100 mg
|
Powder for Solution for Injection (IM/IV)
|
Corticosteroid
|
Kwality Pharmaceuticals Ltd.
|
India
|
Initial
|
02 April 2024
|
02 April 2029
|
| View |
|
DRP-15064
|
Tobramycin
|
Tobrin
|
3 mg/g (0.3% w/w)
|
Sterile Ophthalmic Ointment.
|
Antibiotic
|
Egyptian International Pharmaceutical Industries Co.
|
Egypt
|
Initial
|
02 April 2024
|
02 April 2029
|
| View |
|
DRP-15062
|
Cefixime (as trihydrate)
|
Lefixime 400
|
400 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Innova Captab Ltd.
|
India
|
Initial
|
02 April 2024
|
02 April 2029
|
| View |
|
DRP-15059
|
Tacrolimus (as monohydrate)
|
Cidimus XR
|
5 mg
|
Prolonged-Release Capsule
|
Immunosuppressant (Calcineurin Inhibitor)
|
Lek Pharmaceuticals D.D.
|
Slovenia
|
Initial
|
01 April 2024
|
01 April 2029
|
| View |
|
DRP-15063
|
Cefixime (as trihydrate)
|
Lefixime 200
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Innova Captab Ltd.
|
India
|
Initial
|
02 April 2024
|
02 April 2029
|
| View |
|
DRP-15065
|
Terlipressin (as acetate)
|
Triplessin
|
1 mg/ 10 mL
|
Solution for Injection (I.V.)
|
Vasopressin and Analogues
|
United Biotech Pvt. Ltd.
|
India
|
Initial
|
02 April 2024
|
02 April 2029
|
| View |
|
DRHR-2353
|
Methyl Salicylate + Menthol + Camphor
|
Omega Pain Killer
|
315 mg/ 105 mg /42 mg per gram
|
Cream
|
Counterirritant
|
International Pharmaceuticals, Inc.
|
Philippines
|
Initial
|
04 April 2024
|
04 April 2026
|